Bridgeway Capital Management’s Acrivon Therapeutics ACRV Stock Holding History

Bridgeway Capital Management’s Portfolio ACRV Stock Details ACRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$27.3K	Sell
2025 Q1	$158K	Buy
2024 Q4	$449K	Sell
2024 Q3	$539K	Buy
2024 Q2	$337K	Hold
2024 Q1	$416K	Buy
2023 Q4	$157K	Buy